Carprofen and buprenorphine prevent hyperalgesia in a model of inflammatory pain in cats

Res Vet Sci. 2007 Dec;83(3):369-75. doi: 10.1016/j.rvsc.2007.01.007. Epub 2007 Mar 23.

Abstract

A model of nociceptive threshold determination was developed for evaluation of NSAID analgesia in cats. In a crossover study, eight cats received carprofen (4 mg/kg), buprenorphine (0.01 mg/kg) or saline (0.3 ml) subcutaneously before intradermal kaolin injection on the antebrachium to induce mild inflammation. Pressure thresholds were measured at the injected site using blunt-ended pins advanced by manual inflation of a bladder within a bracelet. Bladder pressure was recorded as threshold (PT) at the behavioural end point. Baseline PT were recorded before kaolin injection (time 0). PT was measured at 2-10 h intervals for 52 h. PT below the lower 95% confidence interval (CI) of baseline values indicated hyperalgesia. After saline, hyperalgesia was detected from 2-6 h, 22-26 h, and at 30 and 36 h. After carprofen, PT remained within the 95% CI. After buprenorphine, PT remained within the 95% CI except at 2h. Carprofen and to some extent buprenorphine, prevented inflammatory hyperalgesia.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Buprenorphine / therapeutic use*
  • Carbazoles / therapeutic use*
  • Cat Diseases / drug therapy*
  • Cats
  • Cross-Over Studies
  • Female
  • Hyperalgesia / drug therapy
  • Hyperalgesia / veterinary*
  • Inflammation / complications*
  • Male
  • Pain / complications
  • Pain / drug therapy
  • Pain / veterinary*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Carbazoles
  • Buprenorphine
  • carprofen